Colorectal Cancer Surgery Quality in Manitoba: A Population-Based Descriptive Analysis.
cancer surgery
colorectal cancer
surgical quality
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
16 06 2021
16 06 2021
Historique:
received:
18
05
2021
revised:
02
06
2021
accepted:
08
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
25
9
2021
Statut:
epublish
Résumé
Unwarranted clinical variation in healthcare impacts access, productivity, performance, and outcomes. A strategy proposed for reducing unwarranted clinical variation is to ensure that population-based data describing the current state of health care services are available to clinicians and healthcare decision-makers. The objective of this study was to measure variation in colorectal cancer surgical treatment patterns and surgical quality in Manitoba and identify areas for improvement. This descriptive study included individuals aged 20 years or older who were diagnosed with invasive cancer (adenocarcinoma) of the colon or rectum between 1 January 2010 and 31 December 2014. Laparoscopic surgery was higher in colon cancer (24.1%) compared to rectal cancer (13.6%). For colon cancer, the percentage of laparoscopic surgery ranged from 12.9% to 29.2%, with significant differences by regional health authority (RHA) of surgery. In 86.1% of colon cancers, ≥12 lymph nodes were removed. In Manitoba, the negative circumferential resection margin for rectal cancers was 96.9%, and ranged from 96.0% to 100.0% between RHAs. The median time between first colonoscopy and resection was 40 days for individuals with colon cancer. This study showed that high-quality colorectal cancer surgery is being conducted in Manitoba along with some variation and gaps in quality. As a result of this work, a formal structure for ongoing measuring and reporting surgical quality has been established in Manitoba. Quality improvement initiatives have been implemented based on these findings and periodic assessments of colorectal cancer surgery quality will continue.
Identifiants
pubmed: 34208635
pii: curroncol28030206
doi: 10.3390/curroncol28030206
pmc: PMC8293066
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2239-2247Références
BMC Surg. 2013;13 Suppl 2:S12
pubmed: 24267544
Gastrointest Cancer Res. 2009 Mar;3(2 Suppl):S33-5
pubmed: 19461921
CMAJ Open. 2018 Sep 18;6(3):E384-E390
pubmed: 30228155
J Laparoendosc Adv Surg Tech A. 2013 Jan;23(1):1-7
pubmed: 23004676
J Am Med Inform Assoc. 2018 Mar 1;25(3):224-229
pubmed: 29025002
J Am Coll Surg. 2007 Nov;205(5):636-41
pubmed: 17964438
Hepatogastroenterology. 2008 Mar-Apr;55(82-83):438-41
pubmed: 18613383
J Surg Oncol. 2013 Nov;108(6):378-84
pubmed: 24037666
Health Place. 1999 Jun;5(2):157-71
pubmed: 10670997
Dis Colon Rectum. 2017 Oct;60(10):999-1017
pubmed: 28891842
Can J Public Health. 2012 Jul 04;103(8 Suppl 2):S23-7
pubmed: 23618067
BMC Res Notes. 2013 Sep 06;6:355
pubmed: 24010527
J Clin Oncol. 2008 Jan 10;26(2):303-12
pubmed: 18182672
Dis Colon Rectum. 2020 Feb;63(2):160-171
pubmed: 31842159
BMC Cancer. 2014 Aug 31;14:642
pubmed: 25175937
Curr Oncol. 2021 Jan 19;28(1):581-592
pubmed: 33478040
Lancet. 2013 Sep 28;382(9898):1121-9
pubmed: 24075052
Science. 1973 Dec 14;182(4117):1102-8
pubmed: 4750608
Dis Colon Rectum. 2018 Apr;61(4):433-440
pubmed: 29521824
Curr Oncol. 2015 Feb;22(1):60-3
pubmed: 25684989
Cancer Res Treat. 2018 Apr;50(2):506-517
pubmed: 28546522
Perm J. 2009 Winter;13(1):47-52
pubmed: 21373245
CMAJ. 2017 Mar 6;189(9):E375-E376
pubmed: 28280071
Can Fam Physician. 2016 Oct;62(10):e599-e607
pubmed: 27737995